cer 2016 dohan equip
TRANSCRIPT
![Page 1: CER 2016 Dohan EQUIP](https://reader030.vdocuments.mx/reader030/viewer/2022020314/58a96a571a28abfd648b5fbd/html5/thumbnails/1.jpg)
EQUIP: Ethnographic and Qualitative Insights for PCOR
Daniel Dohan, PhDProfessor & Deputy Director
February 2, 2016
Integrating New Data and Approaches to Advance Patient Centered Outcomes Research Methods
![Page 2: CER 2016 Dohan EQUIP](https://reader030.vdocuments.mx/reader030/viewer/2022020314/58a96a571a28abfd648b5fbd/html5/thumbnails/2.jpg)
2
What do people like me do?
• Given my personal characteristics, conditions, and preferences, what should I expect will happen to me?
• What are my options, and what are the potential benefits and harms of those options?
What do patients diagnosed with early stage breast cancer decide to do?
Do they decide to pursue aggressive therapy, e.g. prophylactic mastectomy?
Do they take a more conservative treatment route?
![Page 3: CER 2016 Dohan EQUIP](https://reader030.vdocuments.mx/reader030/viewer/2022020314/58a96a571a28abfd648b5fbd/html5/thumbnails/3.jpg)
3
Narratives of decision-making
By KATIE HAFNER SEPT. 28, 2015
![Page 4: CER 2016 Dohan EQUIP](https://reader030.vdocuments.mx/reader030/viewer/2022020314/58a96a571a28abfd648b5fbd/html5/thumbnails/4.jpg)
4
A minority of the people feels that we are going a bit crazy doing mastectomies when people have [DCIS]. It’s noninvasive and everything. And my first thought was, “You know, I’m not gonna have any treatment because I am a healthy person and this would not turn into invasive cancer…” then I had a biopsy and, and then I met with a few people and I read a bit more and…I began to think…how would I face my children if I told them that I was just sort of being arrogant in thinking, “You know, no, personally I’m not into treatment. I think it’s not necessary.” But what if I was worse and this did become invasive, and I have to tell my children that, you know, I did not have treatment because of this. So I began to change my point of view.
![Page 5: CER 2016 Dohan EQUIP](https://reader030.vdocuments.mx/reader030/viewer/2022020314/58a96a571a28abfd648b5fbd/html5/thumbnails/5.jpg)
5http://nyti.ms/1Vn0rhA
By KATIE HAFNER SEPT. 28, 2015
![Page 6: CER 2016 Dohan EQUIP](https://reader030.vdocuments.mx/reader030/viewer/2022020314/58a96a571a28abfd648b5fbd/html5/thumbnails/6.jpg)
6
Methodologically, what should PCOR do with narrative?
Challenges & Opportunities
![Page 7: CER 2016 Dohan EQUIP](https://reader030.vdocuments.mx/reader030/viewer/2022020314/58a96a571a28abfd648b5fbd/html5/thumbnails/7.jpg)
7
• Challenge: Need to innovate to bridge disciplines– Narrative tradition = Dense, lengthy manuscripts
• Paucity of alternatives for communicating narratives to providers, patients, and other PCOR stakeholders
– Distinct intellectual communities for holistic (qualitative) and reductionist (quantitative) scholarship
• Limited common ground on rules of evidence and nature of scholarly and scientific legitimacy
• Opportunity: Engage practice and scholarly communities– Build tools from illness narratives (patients/caregivers)
and clinical judgment (providers)– Engage quantitative and qualitative health scholars to
point out landmines– Identify common ground to support dissemination and
implementation of new tools
![Page 8: CER 2016 Dohan EQUIP](https://reader030.vdocuments.mx/reader030/viewer/2022020314/58a96a571a28abfd648b5fbd/html5/thumbnails/8.jpg)
8
EQUIPCo-Investigators
Corey Abramson, PhD Sociology, University of ArizonaDan Dohan, PhD Sociology/Health Policy, UCSFSarah Garrett, PhD Sociology/Health Policy, UCSFMeghan Halley, PhD Medical Anthropology/Public Health, PAMFRIKate Rendle, PhD Anthropology/Social Work/Public Health, NCI
Pre-Existing Studies (nt = ~ 200)Cancer Patient Deliberation Study (UCSF)Influence of Others on Breast Cancer Treatment Decision Making (PAMFRI)
Stakeholder Advisory Board Non-Experts
Patients Caregivers Clinicians
Experts Ethnographic Methods Numeric and Mixed
Methods Critics
Products1. New standards for use and evaluation of qualitative data in PCOR studies2. New methods…
for analyzing and displaying ethnographic datafor collecting qualitative, patient-centered outcomes data
3. Assessment of accessibility and feasibility of new methods in clinical practice
![Page 9: CER 2016 Dohan EQUIP](https://reader030.vdocuments.mx/reader030/viewer/2022020314/58a96a571a28abfd648b5fbd/html5/thumbnails/9.jpg)
9
Innovation…
Microarray: Tissue samples x genes
Source: Prat, A., and C.M. Perou. 2010. "Deconstructing the molecular portraits of breast cancer." Molecular oncology
![Page 10: CER 2016 Dohan EQUIP](https://reader030.vdocuments.mx/reader030/viewer/2022020314/58a96a571a28abfd648b5fbd/html5/thumbnails/10.jpg)
Instead of tissues & genes…
Strong social supportTrusts the healthcare systemReads medical literatureWilling to travel for TxQuantity v quality of lifeHas a rare diagnosisGood insuranceCommunicates well with MD
…narratives of treatment decisionsAg g Conserv.Conserv.
Ag g
![Page 11: CER 2016 Dohan EQUIP](https://reader030.vdocuments.mx/reader030/viewer/2022020314/58a96a571a28abfd648b5fbd/html5/thumbnails/11.jpg)
Participant 4020 4040 7029* 7046* 7028 4021 7044 7032 4039 7042
Domain Measure Wave 0 1 0 1 0 1 0 1 0 1 0 1 0 1 0 1 0 1 0 1
Decisions
Aggressive ther.
Doctor shop
Clinical Trial
Commun-ication
Trust MD
Talk Lifeworld Team
Health & Illness
Live long time
Daily activities
Zebra Diagnosis
Cancer prognosis
Social Support
Spouse
Network
Hi Social Capital
Insurance & Finance
Health Insurance
Finances
Housing
Higher or More Intense Than Typical Typical Lower or Less Intense Than Typical
Ethnoarray
![Page 12: CER 2016 Dohan EQUIP](https://reader030.vdocuments.mx/reader030/viewer/2022020314/58a96a571a28abfd648b5fbd/html5/thumbnails/12.jpg)
12
EQUIPCo-Investigators
Corey Abramson, PhD Sociology, University of ArizonaDan Dohan, PhD Sociology/Health Policy, UCSFSarah Garrett, PhD Sociology/Health Policy, UCSFMeghan Halley, PhD Medical Anthropology/Public Health, PAMFRIKate Rendle, PhD Anthropology/Social Work/Public Health, NCI
Pre-Existing Studies (nt = ~ 200)Cancer Patient Deliberation Study (UCSF)Influence of Others on Breast Cancer Treatment Decision Making (PAMFRI)
Stakeholder Advisory Board Non-Experts
Patients Caregivers Clinicians
Experts Ethnographic Methods Numeric and Mixed
Methods Critics
Products1. New standards for use and evaluation of qualitative data in PCOR studies2. New methods…
for analyzing and displaying ethnographic datafor collecting qualitative, patient-centered outcomes data
3. Assessment of accessibility and feasibility of new methods in clinical practice
![Page 13: CER 2016 Dohan EQUIP](https://reader030.vdocuments.mx/reader030/viewer/2022020314/58a96a571a28abfd648b5fbd/html5/thumbnails/13.jpg)
13
Stakeholders in EQUIP• Researchers
– Technical and statistical issues in visual displays– Theoretical and epistemological critique– Professional and research infrastructure for
implementation and dissemination• Providers
– Ensure accuracy of clinical information– Insights on feasibility & acceptability in practice
• Patients and caregivers– Code, interpret and transform data– What kinds of narratives matter? Are we getting the
stories right? How can these tools be used to help patients understand their illness and treatment journey?
![Page 14: CER 2016 Dohan EQUIP](https://reader030.vdocuments.mx/reader030/viewer/2022020314/58a96a571a28abfd648b5fbd/html5/thumbnails/14.jpg)
14
A couple closing thoughts• Interesting tensions and challenges have come up
as we seek to engage stakeholders in a technical project, including how to represent engagement to PCORI– In this methodology project, highly specialized
specialists have an essential role– And generalists have (or will develop) special
knowledge and expertise• Given its youth and mandate, PCORI has the
potential to support unorthodox studies– “Skate to where the puck is going to be”
• Wayne Gretzky
![Page 15: CER 2016 Dohan EQUIP](https://reader030.vdocuments.mx/reader030/viewer/2022020314/58a96a571a28abfd648b5fbd/html5/thumbnails/15.jpg)